These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7960626)

  • 1. Reproducibility of magnetic resonance spectroscopy in patients undergoing dialysis and evaluation of the therapeutic response of tumors.
    Imamura K; Ashida H; Nakajima H; Takagi M; Ohashi K; Saeki M; Fukui A; Endo M; Ishikawa T
    Invest Radiol; 1994 Aug; 29(8):758-65. PubMed ID: 7960626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Changes of 3-tesla 31P-MR spectroscopy of bone and soft tissue tumors].
    Qi ZH; Li CF; Ma XX; Li ZF; Zhang K; Yu DX
    Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):442-6. PubMed ID: 19950555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical applicability of human in vivo localized phosphorus-31 magnetic resonance spectroscopy of bone and soft tissue tumors.
    Hoekstra HJ; Boeve WJ; Kamman RL; Mooyaart EL
    Ann Surg Oncol; 1994 Nov; 1(6):504-11. PubMed ID: 7850556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteosarcoma and other neoplasms of bone. Magnetic resonance spectroscopy to monitor therapy.
    Ross B; Helsper JT; Cox IJ; Young IR; Kempf R; Makepeace A; Pennock J
    Arch Surg; 1987 Dec; 122(12):1464-9. PubMed ID: 3479951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapy monitoring in human and canine soft tissue sarcomas using magnetic resonance imaging and spectroscopy.
    Prescott DM; Charles HC; Sostman HD; Dodge RK; Thrall DE; Page RL; Tucker JA; Harrelson JM; Leopold KA; Oleson JR
    Int J Radiat Oncol Biol Phys; 1994 Jan; 28(2):415-23. PubMed ID: 8276656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of bone and soft-tissue tumors with in vivo 1H MR spectroscopy: initial results.
    Wang CK; Li CW; Hsieh TJ; Chien SH; Liu GC; Tsai KB
    Radiology; 2004 Aug; 232(2):599-605. PubMed ID: 15286325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral metabolite patterns in dialysis patients: evaluation with H-1 MR spectroscopy.
    Geissler A; Fründ R; Kohler S; Eichhorn HM; Krämer BK; Feuerbach S
    Radiology; 1995 Mar; 194(3):693-7. PubMed ID: 7862964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [31P-MR spectroscopy of bone and soft tissue lesions].
    Kitagawa A; Saeki M; Imamura K; Ohashi K; Ishikawa T; Nakajima H; Takagi M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1995 Dec; 55(15):1017-24. PubMed ID: 8587841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo 31P nuclear magnetic resonance spectroscopy of osteosarcoma.
    Mooyaart EL; Kamman RL; Boeve WJ
    Cancer Treat Res; 1993; 62():19-24. PubMed ID: 8096733
    [No Abstract]   [Full Text] [Related]  

  • 10. Quantification of phosphorus metabolites in human calf muscle and soft-tissue tumours from localized MR spectra acquired using surface coils.
    Doyle VL; Payne GS; Collins DJ; Verrill MW; Leach MO
    Phys Med Biol; 1997 Apr; 42(4):691-706. PubMed ID: 9127445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined MR imaging and spectroscopy of bone and soft tissue tumors.
    Zlatkin MB; Lenkinski RE; Shinkwin M; Schmidt RG; Daly JM; Holland GA; Frank T; Kressel HY
    J Comput Assist Tomogr; 1990; 14(1):1-10. PubMed ID: 2153717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary study of 3T 1H MR spectroscopy in bone and soft tissue tumors.
    Qi ZH; Li CF; Li ZF; Zhang K; Wang Q; Yu DX
    Chin Med J (Engl); 2009 Jan; 122(1):39-43. PubMed ID: 19187615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of MRS in the differentiation of benign and malignant soft tissue and bone tumors.
    Doganay S; Altinok T; Alkan A; Kahraman B; Karakas HM
    Eur J Radiol; 2011 Aug; 79(2):e33-7. PubMed ID: 21376496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 31-P mr spectroscopy of a leg lymphangiosarcoma.
    Kiricuta IC; Bluemm RG; Krawzak HW; Rühl J; Beyer HK
    Lymphology; 1994 Jun; 27(2):82-9. PubMed ID: 8078364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone and soft-tissue lesions: diagnosis with combined H-1 MR imaging and P-31 MR spectroscopy.
    Negendank WG; Crowley MG; Ryan JR; Keller NA; Evelhoch JL
    Radiology; 1989 Oct; 173(1):181-8. PubMed ID: 2675183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soft-tissue sarcomas: MR imaging and MR spectroscopy for prognosis and therapy monitoring. Work in progress.
    Dewhirst MW; Sostman HD; Leopold KA; Charles HC; Moore D; Burn RA; Tucker JA; Harrelson JM; Oleson JR
    Radiology; 1990 Mar; 174(3 Pt 1):847-53. PubMed ID: 2154837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of musculoskeletal lesions on 3-T proton MR spectroscopy.
    Fayad LM; Barker PB; Jacobs MA; Eng J; Weber KL; Kulesza P; Bluemke DA
    AJR Am J Roentgenol; 2007 Jun; 188(6):1513-20. PubMed ID: 17515370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bone and soft-tissue tumors].
    Shirai Y; Nakase T
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):30-6. PubMed ID: 3002285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance imaging and magnetic resonance spectroscopy of bone tumors and bone marrow disease.
    Lenkinski RE; Listerud J; Shinkwin MA; Zlatkin MB; Kressel HY; Schmidt RG; Daly JM
    Invest Radiol; 1989 Dec; 24(12):1006-10. PubMed ID: 2606629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic characterization of human soft tissue sarcomas in vivo and in vitro using proton-decoupled phosphorus magnetic resonance spectroscopy.
    Li CW; Kuesel AC; Padavic-Shaller KA; Murphy-Boesch J; Eisenberg BL; Schmidt RG; von Roemeling RW; Patchefsky AS; Brown TR; Negendank WG
    Cancer Res; 1996 Jul; 56(13):2964-72. PubMed ID: 8674050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.